Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 3 - Drugs for disorders of the metabolism
Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
11/2012
11/27/2012CA2347131C Modified peptides as therapeutic agents
11/27/2012CA2261231C Process using ulkenia sp. to prepare docosahexaenoic acid and docosapentaenoic acid
11/22/2012WO2012158704A1 Fgfr1 agonists and methods of use
11/22/2012WO2012157721A1 Liposome containing pyrroloquinoline quinone and sugar
11/22/2012WO2012157479A1 Ctrp6 which can be used as therapeutic and prophylactic agent for autoimmune diseases
11/22/2012WO2012157136A1 Rrecombinant human saposin b protein containing phosphorylated glucose ring and use thereof
11/22/2012WO2012156339A1 New hexahydrocyclopentapyrrolone, hexahydropyrrolopyrrolone, octahydropyrrolopyridinone and octahydropyridinone compounds
11/22/2012WO2012156312A1 Pharmaceutical combination for use in the treatment of diabetes type 2
11/22/2012WO2012156299A1 Lixisenatide as add-on therapy to basal insulin in type 2 diabetes
11/22/2012WO2012156298A1 Lixisenatide and metformin for treatment of diabetes type 2
11/22/2012WO2012156296A1 Pharmaceutical combination for use in inducing weight loss in diabetes type 2 patients or/and for preventing weight gain in diabetes type 2 patients
11/22/2012WO2012156225A1 Use of a sulfurated compound for the treatment of hyper-homocysteinemia.
11/22/2012WO2012155780A1 Branched-peg modified glp-1 analogue and pharmaceutically acceptable salts thereof
11/22/2012WO2012155209A1 Methods for treating obesity and/or metabolic syndrome
11/22/2012WO2012134172A3 Composition containing, as an active ingredient, an ethyl acetate fraction of schisandra chinensis baill, or wuweizisu c separated from the fraction, for preventing or treating obesity
11/22/2012WO2012128461A3 Composition comprising black garlic and garcinia cambogia extracts for treating or preventing obesity or hyperlipidemia
11/22/2012WO2012122107A3 Apparatus, system, and method for creating biologically protected/enhanced spaces in vivo
11/22/2012WO2012051107A8 Niacin formulations and methods with reduced flushing side-effect
11/22/2012US20120296403 Methods and compounds for muscle growth
11/22/2012US20120296080 Glucopyranosyl-substituted phenyl derivatives, medicaments containing such compounds, their use and process for their manufacture
11/22/2012US20120296072 N-terminally chemically modified protein compositions and methods
11/22/2012US20120295988 Pharmaceutical Compositions of Dispersions of Amorphous Drugs Mixed with Polymers
11/22/2012US20120295985 Methods for improving blood glucose control
11/22/2012US20120295976 Composition and/or method for preventing recurrence of stroke
11/22/2012US20120295974 Trans-, trans-conjugated linoleic acid compositions and use thereof
11/22/2012US20120295973 Methods and compositions of derivatives of probucol for the treatment of diabetes
11/22/2012US20120295968 Pharmaceutical Composition Comprising Cannabinoids
11/22/2012US20120295958 Modulation of glucagon receptor expression
11/22/2012US20120295954 Treatment of interferon regulatory factor 8 (irf8) related diseases by inhibition of natural antisense transcript to irf8
11/22/2012US20120295950 Rbp4 in insulin sensitivity/resistance, diabetes, and obesity
11/22/2012US20120295947 Processes for the preparation of (r)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl)acetic acid and salts thereof
11/22/2012US20120295943 Cycloalkylamine derivatives
11/22/2012US20120295934 New Hexahydrocyclopentapyrrolone, Hexahydropyrrolopyrrolone, Octahydropyrrolopyridinone and Octahydropyridinone Compounds
11/22/2012US20120295921 Pyridyl piperidine orexin receptor antagonists
11/22/2012US20120295919 Arylpiperazine opioid receptor antagonists
11/22/2012US20120295913 Bicyclic pyrazole compounds as allosteric modulators of mglur5 receptors
11/22/2012US20120295900 1,3-oxazines as bace 1 and/or bace2 inhibitors
11/22/2012US20120295897 Spiro-oxindole compounds and their uses as therapeutic agents
11/22/2012US20120295889 3-Arylamino Pyridine Derivatives
11/22/2012US20120295888 Use of an adrenal hormone-modifying agent
11/22/2012US20120295884 Complement pathway modulators and uses thereof
11/22/2012US20120295882 Tricyclic Derivatives and Their Pharmaceutical Use and Compositions
11/22/2012US20120295877 Therapeutic Compounds
11/22/2012US20120295860 Organic compounds
11/22/2012US20120295847 Acylated GLP-1 Compounds
11/22/2012US20120295846 Pharmaceutical composition comprising a glp-1 agonist, an insulin and methionine
11/22/2012US20120295845 Imidazo-pyrazoles as gpr119 inhibitors
11/22/2012US20120295836 GLP-I Agonist And Cardiovascular Complications
11/22/2012US20120294946 Modulator
11/22/2012US20120294941 Pharmaceutical composition with anti-obesity activity comprising a premixture of pure orlistat and preparation process
11/22/2012US20120294940 Rapidly disintegrating tablet in oral cavity
11/22/2012US20120294939 Direct compression formulation and process
11/22/2012US20120294936 Reduced mass metformin formulations
11/22/2012US20120294895 Protein a compositions and methods of use
11/22/2012US20120294861 Fgfr1 agonists and methods of use
11/22/2012US20120294802 Use of anti-cgrp antibodies and antibody fragments to prevent or inhibit photophobia or light aversion in subjects in need thereof, especially migraine sufferers
11/22/2012US20120294797 Anti-cgrp compositions and use thereof
11/22/2012CA2836599A1 Process for purifying heparan-n-sulfatase
11/22/2012CA2836574A1 Improved peptide pharmaceuticals for insulin resistance
11/22/2012CA2836488A1 Methods for treating obesity and/or metabolic syndrome
11/22/2012CA2835496A1 Pharmaceutical combination for use in inducing weight loss in diabetes type 2 patients or/and for preventing weight gain in diabetes type 2 patients
11/22/2012CA2835336A1 Pharmaceutical combination for use in the treatment of diabetes type 2 patients
11/22/2012CA2835265A1 Lixisenatide as add-on therapy to basal insulin in type 2 diabetes
11/22/2012CA2835259A1 Lixisenatide and metformin for treatment of diabetes type 2
11/22/2012CA2834879A1 Fgfr1 agonists and methods of use
11/22/2012CA2833219A1 Medical food for cognitive decline
11/22/2012CA2832334A1 New hexahydrocyclopentapyrrolone, hexahydropyrrolopyrrolone, octahydropyrrolopyridinone and octahydropyridinone compounds
11/21/2012EP2524917A1 Fused pyridine derivatives
11/21/2012EP2524698A1 Insulin preparation
11/21/2012EP2524697A1 Therapeutic agent for promoting recovery of animal under medical treatment
11/21/2012EP2523958A1 Carboxylic acid derivatives having a 2,5,7-substituted oxazolopyrimidine ring
11/21/2012EP2523953A1 Preparation of 4-amino-thiazoles and 3-amino-1,2,4-thiadiazoles and their use as allosteric modulators of metabotropic glutamate receptors
11/21/2012EP2523946A1 Use of tricyclic sesquiterpene lactones in the treatment of obesity and related diseases and non-therapeutic treatable conditions
11/21/2012EP2523730A1 Methods of treating glucose metabolism disorders
11/21/2012EP2523558A1 Oxadiazole beta carboline derivatives as antidiabetic compounds
11/21/2012CN1980930B 8-[3-amino-piperidin-1-yl]-xanthines, their preparation and the use in the form of a DPP-IV inhibitor
11/21/2012CN1891716B No mitogen activity anti CD3 small molecular antibody designing method
11/21/2012CN102791849A Lactic acid bacterium-containing preparation
11/21/2012CN102791713A Imidazo [1,2-A] pyrazine derivatives and their use for the prevention or treatment of neurological, psychiatric and metabolic disorders and diseases
11/21/2012CN102791701A 3-(3-aminopiperidin-1-yl)-5-oxo-1,2,4-triazine derivates as dipeptidyl peptidase IV(DPP-IV) inhibitors
11/21/2012CN102791699A Fumagillol type compounds and methods of making and using same
11/21/2012CN102791695A Cyclopentyl- and cycloheptylpyrazoles as FXR modulators
11/21/2012CN102791296A Compositions and methods for inhibiting cellular adhesion or directing diagnostic or therapeutic agents to RGD binding sites
11/21/2012CN102791264A Oil and fat composition for prevention or treatment of diabetes
11/21/2012CN102791150A Coffee treatment method
11/21/2012CN102788859A Processed rhubarb or/and raw rhubarb detection method
11/21/2012CN102787054A Wind-dispelling healthcare liquor
11/21/2012CN102786590A Branching-type PEG-modified GLP-1 analogs and pharmaceutically acceptable salts thereof
11/21/2012CN102786525A N-substituted pyrazolo [3, 4-d] pyrimidine ketone compound and preparation method and application thereof
11/21/2012CN102786518A Palmatine hydrochloride crystal B substance, its preparation method, and its applications in medicines and healthcare products
11/21/2012CN102786517A Pyrimidine thiazole amine derivative having GK (glucokinase) and PPAR (peroxidase proliferator-activated receptor) dual agonist activities
11/21/2012CN102786493A 2,3-diaryl thiazolidinone compound and analogue, and purpose thereof in preparing antiangiogenic drugs
11/21/2012CN102786468A Nicotinic acid derivative having GK (glucokinase) and PPAR (peroxidase proliferator-activated receptor) dual agonist activities
11/21/2012CN102786418A Chlorogenic acid crystal II characterization and preparation methods, and applications of chlorogenic acid crystal II in medicines and healthcare products
11/21/2012CN102786417A Chlorogenic acid crystal III characterization and preparation methods, and applications of chlorogenic acid crystal III in medicines and healthcare products
11/21/2012CN102784387A Modified mutant collagenase and it's use in fat melting and in scar reduction
11/21/2012CN102784321A Medicine for treating hypertension, hyperlipidemia and hyperglycemia and preparation method of medicine
11/21/2012CN102784316A Cancer inhibition and flesh engendering medicine for treating burns, scalds, internal and external ulcer and cataract, and its preparation method
11/21/2012CN102784305A Traditional Chinese medicine composition for assisting in decreasing blood sugar and preparation method of traditional Chinese medicine composition
11/21/2012CN102784274A Medicine for treating and nursing diabetic feet
1 ... 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 ... 1298